Global Lab Network Leverage US-based CLIA and CAP-certified labs in combination with Macrogen’s global network to deliver scalable, compliant sequencing across Sanger, NGS, and microarray for multi-site clinical, academic, and consumer projects.

Cutting Edge Capabilities Position for growth in high-value analytics with the Cellanome single-cell platform and expanded spatial biology offerings, including Xenium-related services, plus the Cell Line Authentication service, enabling biotech and pharma customers to access advanced profiling and QC pipelines.

Regulatory Advantage Offer end-to-end, regulatory-ready workflows that support clinical trials, translational research, and quality assurance and validation, appealing to CROs and pharma partners seeking validated sequencing and verification services.

Partnership Engine Demonstrate a strong partnerships ecosystem with Agilent, SeqOne, OmicInsight, and leading instrument providers to enable bundled solutions, integrated workflows, and co-developed offerings with clear cross-sell opportunities.

Growth and Scale Growing footprint and diversified services suggest capacity to win larger, longer-term engagements with mid-market biotechs and CROs, with opportunities to tailor tiered service packages and long-term contracts.